Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Osteoarthritis

In brief

This was a multicenter, randomized, double-blind, placebo-controlled Phase IIb study evaluating intra-articular LNA043 in patients with knee osteoarthritis.

Key facts

Study ID
NCT04864392
Run by
Novartis Pharmaceuticals
People needed
576
Starts
2021-05-31
Expected to finish
2025-05-29
Last updated by the study team
2026-04-02

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.